133 related articles for article (PubMed ID: 24917751)
1. The use of a memokath prostatic stent for obstructive voiding symptoms after brachytherapy.
de Graaf GW; Stijns PE; Scheepens WA; van Moorselaar RJ; Hendrikx AJ
Curr Urol; 2013 Aug; 7(1):19-23. PubMed ID: 24917751
[TBL] [Abstract][Full Text] [Related]
2. Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptoms.
Dineen MK; Shore ND; Lumerman JH; Saslawsky MJ; Corica AP
Urology; 2008 May; 71(5):873-7. PubMed ID: 18374395
[TBL] [Abstract][Full Text] [Related]
3. Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.
Brousil P; Hussain M; Lynch M; Laing RW; Langley SE
BJU Int; 2015 Apr; 115(4):580-6. PubMed ID: 24802744
[TBL] [Abstract][Full Text] [Related]
4. Management of intractable bladder neck strictures following radical prostatectomy using the Memokath
Nathan A; Mazzon G; Pavan N; De Groote R; Sridhar A; Nathan S
J Robot Surg; 2020 Aug; 14(4):621-625. PubMed ID: 31617064
[TBL] [Abstract][Full Text] [Related]
5. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a thermoexpandable metallic prostate stent (Memokath) in elderly patients with urethral obstruction requiring long-term management with urethral Foley catheters.
Kimata R; Nemoto K; Tomita Y; Takahashi R; Hamasaki T; Kondo Y
Geriatr Gerontol Int; 2015 May; 15(5):553-8. PubMed ID: 24852087
[TBL] [Abstract][Full Text] [Related]
7. A novel temporary prostatic stent for the relief of prostatic urethral obstruction.
Corica AP; Larson BT; Sagaz A; Corica AG; Larson TR
BJU Int; 2004 Feb; 93(3):346-8. PubMed ID: 14764134
[TBL] [Abstract][Full Text] [Related]
8. Thermo-expandable intra-prostatic stent in the treatment of acute urinary retention in elderly patients with significant co-morbidities.
Lee G; Marathe S; Sabbagh S; Crisp J
Int Urol Nephrol; 2005; 37(3):501-4. PubMed ID: 16307329
[TBL] [Abstract][Full Text] [Related]
9. A Spanner in the works: the use of a new temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy.
Henderson A; Laing RW; Langley SE
Brachytherapy; 2002; 1(4):211-8. PubMed ID: 15062169
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
Chan CK; Yip SK; Wu IP; Li ML; Chan NH
BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
Blaivas JG; Weiss JP; Jones M
BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
[TBL] [Abstract][Full Text] [Related]
12. Urolume stent placement for the treatment of postbrachytherapy bladder outlet obstruction.
Konety BR; Phelan MW; O'Donnell WF; Antiles L; Chancellor MB
Urology; 2000 May; 55(5):721-4. PubMed ID: 10792088
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer.
Choi SY; Lim B; Chi BH; Kim JH; Lee W; Kyung YS; You D; Song HY; Kim CS
Low Urin Tract Symptoms; 2021 Jul; 13(3):329-334. PubMed ID: 33768708
[TBL] [Abstract][Full Text] [Related]
14. Correlation between international prostate symptom score and uroflowmetry in patients with benign prostatic hyperplasia.
Oranusi CK; Nwofor AE; Mbonu O
Niger J Clin Pract; 2017 Apr; 20(4):454-458. PubMed ID: 28406126
[TBL] [Abstract][Full Text] [Related]
15. (125)Iodine prostate brachytherapy: outcome from the first 100 consecutive patients and selection strategies incorporating urodynamics.
Henderson A; Cahill D; Laing RW; Langley SE
BJU Int; 2002 Oct; 90(6):567-72. PubMed ID: 12230619
[TBL] [Abstract][Full Text] [Related]
16. Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
Yan M; Xue P; Wang K; Gao G; Zhang W; Sun F
Strahlenther Onkol; 2017 Sep; 193(9):714-721. PubMed ID: 28612083
[TBL] [Abstract][Full Text] [Related]
17. Improved irritative voiding symptoms 3 years after stereotactic body radiation therapy for prostate cancer.
Rana Z; Cyr RA; Chen LN; Kim BS; Moures RA; Yung TM; Lei S; Collins BT; Suy S; Dritschilo A; Lynch JH; Collins SP
Front Oncol; 2014; 4():290. PubMed ID: 25374844
[TBL] [Abstract][Full Text] [Related]
18. Urinary symptom flare following I-125 prostate brachytherapy.
Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1085-92. PubMed ID: 12829146
[TBL] [Abstract][Full Text] [Related]
19. Interstitial laser coagulation and biodegradable self-expandable, self-reinforced poly-L-lactic and poly-L-glycolic copolymer spiral stent in the treatment of benign prostatic enlargement.
Laaksovirta S; Isotalo T; Talja M; Välimaa T; Törmälä P; Tammela TL
J Endourol; 2002 Jun; 16(5):311-5. PubMed ID: 12184083
[TBL] [Abstract][Full Text] [Related]
20. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study.
Henderson A; Ismail AK; Cunningham M; Aldridge S; Loverock L; Langley SE; Laing RW
Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):95-104. PubMed ID: 15074730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
